Industry

European investment figures point to an evolving alternative protein sector

Scale-up series part 3: Build a force-multiplying team

In part three of our scale-up series, we explore the best way to plan and build a rock-solid team for your startup, and set the company up for success.

Meet the researcher: Boosting alternative protein research at ICL’s new Bezos Centre for Sustainable Proteins with Rodrigo Ledesma-Amaro

A new centre based at Imperial College London aims to revolutionise the development of alternative proteins.

Scale-up series part 2: Your target market(s) may change over time, and that’s okay

In part two of our new scale-up series, we highlight the importance of finding the right market for your product at every stage of growth.

Planting the seeds of change – how Europe’s farmers can reap the benefits of plant-based foods

As the appetite for plant-based food grows across Europe, these products present new opportunities for farmers to produce the raw ingredients they need.

Scale-up series part 1: What do you want to be when you grow up? 4 guiding principles for startups looking to scale

In part one of our new scale-up series, we explore 4 essential questions to help new entrants set themselves up for scaling success.

Biotech Heights, the public-private collaboration to boost home-grown protein diversification in Sweden

A trip to Biotech Heights, a newly launched public-private partnership initiative based in Sweden.

Italian Government ‘open’ to reconsidering ban on meaty terms

Italian Agriculture Minister Francesco Lollobrigida has told Parliament the government is talking to plant-based meat companies to hear their concerns about a ban on using ‘meaty’ terms.

APP 2024: join the student movement shaping the future of food

From Portugal to Türkiye – students across Europe are taking a leading role in a global movement turning universities into dynamic engines for alternative protein innovation.

Europe aspires to lead in cleantech and biotech – but they need alternative proteins to win the race

It's time for policymakers to rethink their approach, and give the same level of priority to alternative proteins as they do to other promising biotech and cleantech fields.